Copyright
©The Author(s) 2016.
World J Stem Cells. Apr 26, 2016; 8(4): 118-135
Published online Apr 26, 2016. doi: 10.4252/wjsc.v8.i4.118
Published online Apr 26, 2016. doi: 10.4252/wjsc.v8.i4.118
Diseases | Genetic defects | Target cells for reprogramming | Delivery methods | Disease relevant cells | Ref. |
Huntington’s disease (OMIM #143100) | Expanded CAG repeat in HTT gene | HF | Lentiviral vectors (O, S, K, M, NANOG and LIN28) | Neurons | [79] |
HF | Retroviral vectors (O, S, K, M) | Astrocytes | [80] | ||
HF | Lentiviral vectors (O, S, K, M) | Neurons | [81] | ||
HF | Retroviral vectors (O, S, K, M) | Neurons | [82] | ||
HF | Retroviral vectors (O, S, K, M) | GABAergic neurons | [83] | ||
HF | Retroviral vectors (O, S, K, M) | Striatal neurons | [84] | ||
Marfan syndrome (OMIM #154700) | FBN1 mutations | HF | Retroviral vectors (O, S, K, M) | Osteogenic cells chondrogenic cells | [87] |
Myotonic dystrophy type 1 (OMIM #160900) | Expanded CTG repeat in DMPK gene | HF | Retroviral vectors (O, S, K, M) | NS | [92] |
HF | Retroviral vectors (O, S, K, M) | NSC | [94] | ||
Achondroplasia (OMIM #100800) | FGFR3 mutations | HF | Episomal plasmid vectors (O, S, K, M, LIN28 and p53 shRNA) | Chondrocytes | [97] |
Familial hypercholesterolemia (OMIM #143890) | LDLR mutations | HF | Retroviral vectors (O, S, K, M) | HLC | [99] |
HF | Lentiviral vectors (O, S, NANOG, LIN28) | Hepatocytes | [100] | ||
HF | Retroviral vectors (O, S, K, M) | HLC | [101] | ||
Timothy syndrome (OMIM #601005) | CACNA1C mutations | HF | Retroviral vectors (O, S, K, M) | Cardiac myocytes | [102] |
HF | Retroviral vectors (O, S, K, M) | Cortical neuronal precursor cells and neurons | [103] | ||
HF | Retroviral vectors (O, S, K, M) | Cortical neuronal precursor cells and neurons | [104] |
Diseases | Genetic defects | Target cells for reprogramming | Delivery methods | Disease relevant cells | Ref. |
Spinal muscular atrophy (OMIM #253300) | SMN1 mutations | HF | Lentiviral vectors (O, S, NANOG, LIN28) | Neurons/astrocytes/motor neurons | [109] |
HF | Retroviral vectors (O, S, K, M) | Motor neurons | [110] | ||
HF | Lentiviral vectors (O, S, NANOG, LIN28) | Motor neurons | [112] | ||
HF | Retroviral vectors (O,S, K, M) | GABAergic neurons | [113] | ||
β-thalassaemia (OMIM #613985) | Point mutations or deletions in the β-globin (HBB) gene | HF/AF/CVS | Retroviral vectors (O, S, K, M) | Hematopoietic cells | [116] |
AF | Lentiviral vectors (O, S, K, M) | Hematopoietic cells | [118] | ||
HF/MSCs | Lentiviral vectors (O, S, K, M) | Erythroid cells | [119] | ||
HF | PiggyBac transposon | Hematopoietic cells | [120] | ||
Cystic fibrosis (OMIM #219700) | CFTR mutations | HF | Lentiviral vectors (O, S, K, M) | Mature airway epithelial cells | [126] |
HF | Modified RNAs (RiPSC) | Mature airway epithelial cells | [127] | ||
HF | Retroviral vectors (O, S, K, M) | Mature airway epithelial cells | [128] | ||
HF | Retroviral vectors (O, S, K, M) | CLCs | [130] | ||
Sickle cell disease (OMIM #603903) | HBB mutations | HF | Retroviral vectors (O, S, K, M) | Erythrocytes | [135] |
HF | Lentiviral vectors (O, S, K, M) | None | [136] | ||
Hutchinson-gilford progeria syndrome (OMIM #176670) | LMNA mutations | HF | Retroviral vectors (O, S, K, M) | Neural progenitors, endothelial cells, fibroblasts, VSMCs, and MSCs | [137] |
HF | Retroviral vectors (O, S, K, M) | Vascular SMCs | [138] | ||
HF | Retroviral vectors (O, S, K, M) | MSCs and osteogenic cells | [139] | ||
Niemann–pick disease type C1 (OMIM #257220) | NPC1 mutations | HF | Retroviral vectors (O, S, K, M) | Neurons | [140] |
HF | Lentiviral vectors (O, S, K, M) | Neurons | [141] | ||
HF | SeV vectors (O, S, K, M) | HLCs and neural progenitors | [142] |
Diseases | Genetic defects | Target cells for reprogramming | Delivery methods | Disease relevant cells | Ref. |
Fragile X syndrome (OMIM #300624) | FMR1 silencing | HF | Retroviral vectors (O, S, K, M) | Neurons | [146] |
HF | Retroviral vectors (O, S, K, M) | Forebrain Neurons | [147] | ||
HF | Sendai virus | NPC | [148] | ||
Duchenne muscular dystrophy (OMIM #310200) | Dystrophin gene mutations | HF | Retroviral vectors (O, S, K, M) | Myogenic cells | [154] |
HF | Retroviral vectors (O, S, K, M) | CMs | [155] | ||
HF | Retroviral vectors (O, S, K, M) | Neurons | [156] | ||
Wiskott-aldrich syndrome (OMIM #301000) | WASP mutations | HF | Retroviral vectors/sendai virus vectors (O, S, K, M) | Megakaryocytes | [157] |
Rett syndrome (OMIM #312750) | MeCP2/CDKL5 mutations | HF | Retroviral vectors (O, S, K, M) | Neurons | [158] |
HF | Retroviral vectors (O, S, K, M) | NPCs/mature neurons | [159] | ||
HF | Retroviral vectors (O, S, K, M) | NPCs/mature neurons | [160] | ||
Hemophilia A (OMIM #306700) | Deficiency of factor VIII | Urine cells | Episomal vectors (O, S, K, SV40LT) | Hepatocytes | [161] |
- Citation: Spitalieri P, Talarico VR, Murdocca M, Novelli G, Sangiuolo F. Human induced pluripotent stem cells for monogenic disease modelling and therapy. World J Stem Cells 2016; 8(4): 118-135
- URL: https://www.wjgnet.com/1948-0210/full/v8/i4/118.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v8.i4.118